statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aptorum Group Limited (Nasdaq: APM) (Aptorum Group or We), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious...

Aptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business Update

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Aptorum Group Ltd trading halted, volatility trading pause

Aptorum Group Ltd trading resumes

Acciones al alza
Aptorum Gr (NASDAQ:APM) experimentaron un repunte del 680,24% para establecerse en los 11,31 d lares durante la sesi n del regular del mi rcoles.
NKGen Biotech (NASDAQ:NKGN...

12 acciones de salud en movimiento en la sesi n intrad a del 06/03/2024

BeyondSpring, enVVeno Medical, Aptorum Group among healthcare movers...

BeyondSpring, enVVeno Medical, Aptorum Group among healthcare movers

Aptorum Group Limited (Nasdaq: APM), a clinical stage biopharmaceutical company (Aptorum), and privately-held YOOV Group Holding Ltd. (YOOV) jointly announced today that they entered into an...

Aptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy Business

Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.

Aptorum Group Ltd - Ordinary Shares - Class A

Volume	7,780.00
52-Wk High	$17.49
52-Wk Low	$1.35

APM Aptorum Group Ltd - Ordinary Shares - Class A

About

Feed

News

Sentiment

Fundamentals

Sentiment

Message Volume

Community